Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00XQK
|
||||
Former ID |
DIB003722
|
||||
Drug Name |
HRC-102
|
||||
Synonyms |
Hemolox T; HML-110
|
||||
Indication | Reperfusion injury [ICD10:I00-I99] | Terminated | [547482] | ||
Company |
Ontario Inc
|
||||
Target and Pathway | |||||
Target(s) | Hemoglobin | Target Info | Modulator | [550172] | |
KEGG Pathway | African trypanosomiasis | ||||
Malaria | |||||
WikiPathways | Binding and Uptake of Ligands by Scavenger Receptors | ||||
Uptake of Carbon Dioxide and Release of Oxygen by Erythrocytes | |||||
Uptake of Oxygen and Release of Carbon Dioxide by Erythrocytes | |||||
Factors involved in megakaryocyte development and platelet production | |||||
Folate Metabolism | |||||
Vitamin B12 Metabolism | |||||
Selenium Micronutrient Network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.